Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G van Lingen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Dermatological Treatment|January 23, 2009
Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: a pilot studyRosanne G van Lingen, Elke M G J de Jong, Maartje A M Berends, et al.
Journal of Cutaneous Pathology|August 18, 2009
The universal detection of antigens from one skin biopsy specimenHaike M J van der Velden, Peter C M van de Kerkhof, Marcel C Pasch, et al.
European Journal of Dermatology : EJD|October 29, 2008
Nd: YAG laser (1,064 nm) fails to improve localized plaque type psoriasis: a clinical and immunohistochemical pilot studyRosanne G van Lingen, Elke M G J de Jong, Piet E J van Erp, et al.
The Journal of Dermatological Treatment|January 9, 2010
Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical studyHaike M J van der Velden, Marcel C Pasch, Piet E J van Erp, et al.
Acta Dermato-Venereologica|September 8, 2009
Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvementRosanne G van Lingen, Piet E J van Erp, Marieke M B Seyger, et al.
The British Journal of Dermatology|April 4, 2008
CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changesR G van Lingen, P C M van de Kerkhof, M M B Seyger, et al.
The British Journal of Dermatology|May 15, 2008
Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapiesR G van Lingen, J E M Körver, P C M van de Kerkhof, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Dermatological Treatment|January 23, 2009
Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: a pilot studyRosanne G van Lingen, Elke M G J de Jong, Maartje A M Berends, et al.
Journal of Cutaneous Pathology|August 18, 2009
The universal detection of antigens from one skin biopsy specimenHaike M J van der Velden, Peter C M van de Kerkhof, Marcel C Pasch, et al.
European Journal of Dermatology : EJD|October 29, 2008
Nd: YAG laser (1,064 nm) fails to improve localized plaque type psoriasis: a clinical and immunohistochemical pilot studyRosanne G van Lingen, Elke M G J de Jong, Piet E J van Erp, et al.
The Journal of Dermatological Treatment|January 9, 2010
Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical studyHaike M J van der Velden, Marcel C Pasch, Piet E J van Erp, et al.
Acta Dermato-Venereologica|September 8, 2009
Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvementRosanne G van Lingen, Piet E J van Erp, Marieke M B Seyger, et al.
The British Journal of Dermatology|April 4, 2008
CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changesR G van Lingen, P C M van de Kerkhof, M M B Seyger, et al.
The British Journal of Dermatology|May 15, 2008
Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapiesR G van Lingen, J E M Körver, P C M van de Kerkhof, et al.
Pageof 2